Based on the domestic demand for innovative research and development of all human antibody drugs, with solid technological innovation strength, baicalto has independently developed the renmise platform for all human antibody mice and owns renmab®Mice、RenLite®Mice(Common Light Chain), it can meet the diversified new drug R & D scenarios such as all human monoclonal antibody drug R & D and double / multispecific antibody drug R & D, and help global pharmaceutical enterprises accelerate the drug development process.